Logos Global Management LP Kal Vista Pharmaceuticals, Inc. Transaction History

Logos Global Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$8.95 - $11.35 $8.05 Million - $10.2 Million	900,000 New	900,000 $8.67 Million
Q1 2021 May 17, 2021	SELL	$14.69 - $42.57 $7.2 Million - $20.9 Million	-490,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.88 - $19.47 $2.45 Million - $3.7 Million	190,000 Added 63.33%	490,000 $9.31 Million
Q3 2020 Nov 16, 2020	SELL	$9.83 - $13.99 $2.58 Million - $3.68 Million	-262,900 Reduced 46.7%	300,000 $3.78 Million
Q2 2020 Aug 14, 2020	BUY	$6.75 - $12.89 $3.8 Million - $7.26 Million	562,900 New	562,900 $6.81 Million

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.